Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 12:08PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-2.30 Insider Own17.84% Shs Outstand10.85M Perf Week-13.07%
Market Cap10.09M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float8.92M Perf Month-41.50%
Income-12.62M PEG- EPS next Q- Inst Own2.34% Short Float7.15% Perf Quarter-24.99%
Sales0.03M P/S336.39 EPS this Y- Inst Trans-81.20% Short Ratio0.56 Perf Half Y-50.26%
Book/sh0.75 P/B1.24 EPS next Y- ROA-95.10% Short Interest0.64M Perf Year-86.63%
Cash/sh0.07 P/C13.82 EPS next 5Y- ROE-233.43% 52W Range0.67 - 7.04 Perf YTD-19.82%
Dividend Est.- P/FCF- EPS past 5Y12.78% ROI-151.45% 52W High-86.78% Beta0.76
Dividend TTM- Quick Ratio0.27 Sales past 5Y2003.75% Gross Margin-918.83% 52W Low38.02% ATR (14)0.09
Dividend Ex-DateSep 16, 2013 Current Ratio0.27 EPS Y/Y TTM39.13% Oper. Margin-38460.41% RSI (14)33.65 Volatility3.86% 8.37%
Employees19 Debt/Eq0.34 Sales Y/Y TTM-97.63% Profit Margin-49776.99% Recom3.00 Target Price20.20
Option/ShortNo / Yes LT Debt/Eq0.04 EPS Q/Q26.73% Payout- Rel Volume0.78 Prev Close1.03
Sales Surprise- EPS Surprise- Sales Q/Q-99.06% EarningsNov 15 BMO Avg Volume1.15M Price0.93
SMA20-17.17% SMA50-20.08% SMA200-25.81% Trades Volume386,760 Change-9.57%
Today 09:00AM
May-22-24 09:00AM
May-17-24 10:52PM
May-15-24 11:14AM
09:35AM Loading…
May-09-24 09:35AM
Apr-18-24 09:25AM
Apr-17-24 09:00AM
Apr-10-24 08:30AM
Mar-26-24 08:30AM
Mar-21-24 08:30AM
Mar-19-24 08:30AM
Mar-14-24 09:30AM
Feb-27-24 08:30AM
Feb-15-24 08:30AM
08:30AM Loading…
Feb-12-24 08:30AM
Feb-08-24 09:17AM
Jan-03-24 07:24AM
Dec-07-23 08:30AM
Dec-05-23 08:30AM
Nov-21-23 08:30AM
Nov-16-23 10:05AM
Nov-15-23 09:00AM
Oct-26-23 08:30AM
Oct-17-23 08:30AM
Oct-09-23 08:30AM
Aug-23-23 08:30AM
Aug-17-23 09:19AM
Aug-10-23 08:30AM
Aug-07-23 08:30AM
09:20AM Loading…
Aug-03-23 09:20AM
Aug-01-23 08:30AM
Jul-31-23 09:30AM
Jul-27-23 09:22AM
Jul-26-23 08:30AM
Jul-24-23 12:30PM
Jul-06-23 08:30AM
Jun-26-23 08:30AM
Jun-20-23 08:30AM
Jun-12-23 08:30AM
Jun-06-23 08:30AM
May-22-23 08:30AM
May-04-23 08:30AM
Apr-26-23 08:30AM
Apr-10-23 08:30AM
Apr-06-23 08:30AM
Mar-31-23 06:49PM
Mar-20-23 07:00AM
Mar-14-23 07:00AM
Feb-28-23 08:30AM
Feb-23-23 04:16PM
Feb-21-23 08:30AM
Jan-19-23 08:30AM
Jan-18-23 08:25AM
Jan-05-23 08:30AM
Dec-20-22 11:05AM
Nov-17-22 08:30AM
Nov-14-22 06:20PM
Nov-07-22 08:30AM
Nov-02-22 08:30AM
Oct-05-22 08:30AM
Sep-23-22 08:30AM
Sep-16-22 09:36AM
Sep-13-22 08:30AM
Sep-09-22 08:30AM
Aug-22-22 08:30AM
Aug-18-22 08:30AM
Aug-15-22 05:48PM
Aug-02-22 08:30AM
Jul-18-22 08:30AM
Jul-13-22 08:30AM
Jul-06-22 08:30AM
Jun-30-22 08:30AM
Jun-21-22 08:30AM
Jun-16-22 08:30AM
Jun-10-22 08:30AM
Jun-07-22 01:10PM
Jun-01-22 08:30AM
May-25-22 08:30AM
May-23-22 07:30AM
May-16-22 05:46PM
May-13-22 08:30AM
May-12-22 09:00AM
May-10-22 08:30AM
May-05-22 08:30AM
May-03-22 08:30AM
Apr-28-22 08:30AM
Apr-26-22 08:30AM
Mar-31-22 04:18PM
Mar-23-22 09:25AM
Mar-08-22 06:15AM
Feb-02-22 08:00AM
Jan-05-22 08:30AM
Dec-22-21 08:30AM
Dec-15-21 08:30AM
Dec-10-21 01:38PM
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.